Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 20.30
-0.30 (-1.46%)
At close: Jul 15, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 900.2 million as of July 15, 2026. Its market cap has decreased by -18.47% in one year.
Market Cap
900.20M
Enterprise Value
894.37M
Revenue
449.47M
Ranking
n/a
PE Ratio
12.08
Stock Price
20.30
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 900.20M, an increase of 179.27%. That is a compound annual growth rate of 9.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 900.20M | -2.40% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.17B |
| Circio Holding ASA | 1.75B |
| Nordhealth AS | 1.75B |
| Photocure ASA | 1.54B |
| ArcticZymes Technologies ASA | 967.80M |
| Nykode Therapeutics AS | 917.60M |
| INIFY Laboratories AB | 849.05M |
| Lytix Biopharma ASA | 767.46M |